Opening book details…
About this Medicine article
Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma by Tong, Wei Gang (author);Chen, Rong (author);Plunkett, William (author);Siegel, David (author);Sinha, Rajni (author);Harvey, R. Donald (author);Badros, Ashraf Z. (author);Popplewell, Leslie (author);Coutre, Steven (author);Fox, Judith A. (author);Mahadocon, Kristi (author);Chen, Tianling (author);Kegley, Peggy (author);Hoch, Ute (author);Wierda, William G. (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Tong, Wei Gang (author);Chen, Rong (author);Plunkett, William (author);Siegel, David (author);Sinha, Rajni (author);Harvey, R. Donald (author);Badros, Ashraf Z. (author);Popplewell, Leslie (author);Coutre, Steven (author);Fox, Judith A. (author);Mahadocon, Kristi (author);Chen, Tianling (author);Kegley, Peggy (author);Hoch, Ute (author);Wierda, William G. (author)
- Publisher
- American Society of Clinical Oncology; American Society of Clinical Oncology (ASCO) (ISSN 0732-183X)
- Published
- 2010
- Field
- Medicine (Health Sciences)